Bioburden Testing Market to Exceed more than US$ 907 Million By - Erie News Now | WICU & WSEE in Erie, PA

Bioburden Testing Market to Exceed more than US$ 907 Million By 2022

Posted:

New York, September 25, 2017 /Financeswire/: Market Research Engine has published a new report titled as “Bioburden Testing Market By Product Analysis (Consumables, Instruments); By Test Type Analysis (Aerobic Count, Anaerobic Count, Fungi/Mold Count, Spores Count); By Application Type Analysis (Raw Material Testing, Medical Devices Testing, In-process Testing, Sterilization Validation Testing, Equipment Cleaning Validation); By End-User Analysis (Pharmaceutical and Biotechnology Companies, Medical Device Manufacturers, Contract Manufacturing Organizations (CMOs), Manufacturers of Food & Beverage and Agricultural Products, Microbial Testing Laboratories) and by regional analysis – global forecast by 2016 – 2022”

The Global Bioburden Testing Market is segmented on the lines of its technology, treatment, application and regional. Basis on product type it covers Consumables and Instruments. Based on Test-type analysis the market is segmented into Aerobic Count, Anaerobic Count, Fungi/Mold Count and Spores Count. Based on application, the market is segmented into Raw Materials Testing, Medical Devices Testing, In-Process Material Testing, Sterilization, Validation Testing and Equipment Cleaning Validation. Based on End-user type it covers Pharmaceutical & Biotechnology Companies, Medical Device Manufacturers, Contract Manufacturing Organizations (CMOS), Manufacturers of Food & Beverage and Agriculture Products, Microbial Testing and Laboratories. Global Bioburden Testing Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The Global Bioburden Testing Market is expected to exceed more than US$ 907.4 Million by 2022 at a CAGR of 8.5% in the given forecast period.

Browse Full Report: https://www.marketresearchengine.com/bioburden-testing-market

The major driving factors of Global Bioburden Testing Market are as follows:

  • Growing Medical Device, Pharmaceutical and Biotechnology Industries
  • Increasing Food & liquid Safety considerations
  • Increasing Product Recall because of microbial Contamination
  • Strong Trend of R&D Investments in Life Sciences
  • Growing health care business and Medical spending

The restraining factors of Global Bioburden Testing Market are as follows:

  • High Costs of Microbial Enumeration Instruments

This report provides:

1) An overview of the global market for Global Bioburden Testing Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for using topical acne treatment Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

Report Scope:

The scope of the report includes a detailed study of global and regional markets for Global Bioburden Testing Market with the reasons given for variations in the growth of the industry in certain regions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the Charles River Laboratories International Inc., Sigma-Aldrich Corporation, SGS S.A., Wuxi Pharmatech (CAYMAN) Inc., Merck & Co. Inc., Becton, Dickinson, and Company, North American Science Associates Inc., Nelson Laboratories Inc., Pacific Biolabs, and ATS Labs Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The Global Bioburden Testing Market has been segmented as below:

By Product Analysis:

  • Consumables
  • Culture Media and Reagents Kits
  • Other Consumables
  • Instruments
  • Automated Microbial Identification Systems
  • Polymerase Chain Reaction (PCR)
  • Microscopes
  • Other Instruments

By Test Type Analysis:

  • Aerobic Count
  • Anaerobic Count
  • Fungi/Mold Count
  • Spores Count

By Application Type Analysis:

  • Raw Material Testing
  • Medical Devices Testing
  • In-process Testing
  • Sterilization Validation Testing
  • Equipment Cleaning Validation

By End-User Analysis:

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • Manufacturers of Food & Beverage and Agricultural Products
  • Microbial Testing Laboratories

By Regional Analysis:

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

 

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: john@marketresearchengine.com

Phone: +1-855-984-1862

Country: United States

Website: https://www.marketresearchengine.com/

 

Source: http://www.financeswire.com/bioburden-testing-market-to-exceed-more-than-us-907-million-by-2022

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@franklyinc.com

Powered by Frankly
3514 State St. Erie, PA 16508
Newsroom: (814) 454-8812
Business offices: (814) 454-5201
WICU FCC Filing
WSEE FCC Filing
Share:
Share Stories
Submit your stories to our site!
Share Photos
Share your photos in our community galleries
RSS Feeds
All content © Copyright 2000 - 2017 WICU. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.
                   WICU/WSEE - 3514 State Street Erie, PA 16508 - (814) 454-5201 - info@wicu12.com